Hepatitis B is a liver infection that inflames the organ and impacts its ability to function. It can be either acute (short-term) or chronic (long-term), and is estimated to impact between 880,000 ...

Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the benefits of vaccination. The company—which makes hepatitis B vaccine ...

The tournament kicks off the seven-leg Visayas-Mindanao (Vis-Min) series, with junior golfers vying for individual leg titles and ranking points for a coveted slot in the North vs South Elite ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Background: The safety and immunogenicity of Viatim, a combined hepatitis A (HA) and typhoid fever (Vi) vaccine, were compared with the monovalent component vaccines up to and 1 month after a ...

Interventions Identified to Eliminate Transmission of Hepatitis B in Africa Feb. 27, 2025 — A new study that has the potential to change the landscape of hepatitis B transmission in Africa.

Apr. 18, 2025 — A team led by researchers say public ignorance and apathy towards bird flu (highly pathogenic avian influenza, or HPAI) could pose a serious obstacle to containing the virus and ...